Topic Boehringer Ingelheim

Companies Boehringer Ingelheim

News Boehringer Ingelheim

• Nanobody for Alzheimer's disease moves closer toward phase I clinical trial

  Ablynx announced that Boehringer Ingelheim has submitted a Clinical Trials Application (CTA)  to the European regulatory authorities to start a Phase I clinical trial with a Nanobody® for the treatment of Alzheimer's disease. The Nanobody has been developed as part of the collaboration signed betwee more

• Ablynx announces an extension of its global strategic nanobody alliance with Boehringer Ingelheim

  Ablynx announced a two-year extension of the initial five-year research funding by Boehringer Ingelheim of their global strategic alliance to discover, develop and commercialise up to 10 different Nanobody® therapeutics. The extension which will run until September 2014, will allow all the existing more

• Ablynx receives another milestone as Boehringer Ingelheim selects Nanobody candidate for pre-clinical development

  Ablynx announced that Boehringer Ingelheim has selected, as part of their strategic alliance, a second Nanobody® candidate for pre-clinical development, which triggered a €5 million milestone payment to Ablynx. The Nanobody development candidate is designed to interfere with the function of two dist more

Publications Boehringer Ingelheim

• Sensory transduction, the gateway to perception: mechanisms and pathology

  Sensory transduction, the gateway to perception: mechanisms and pathology EMBO Reports 12, 292 (2011). doi:10.1038/embor.2011.45 Authors: Stefan G Lechner & Jan Siemens The 102nd biannual Boehringer Ingelheim Fonds International Titisee Conference took place in October 2010. more

Market studies Boehringer Ingelheim

• Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more

• Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020”. The report is an essential source of information and analysis on the global ovarian cancer therapeutics market. The report provi more

• Abbott Laboratories Market Share Analysis

  Introduction GlobalData’s new report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott Laboratories’s market position in the different medical equipment markets it operates in. The report provides Abbott Laboratories market share information in 10 key market cate more